ETF Battles ARKG vs. GNOM – What’s the better genomic/biotech play?

Are you ready to go to rumble? In this episode of ETF Battles you’ll see a clash between the ARK Genomics Revolution ETF (ARKG) vs. the Global X Genomics & Biotechnology ETF (GNOM). Which ETF is the better play?

Ron DeLegge @ETFguide referees the matchup with guest judges Cinthia Murphy at ETF.com and Dave Kreinces at ETF Portfolio Management providing their research insights.

Each ETF is judged against the other in key categories like cost, exposure strategy, performance and a mystery category. Find out who wins the battle!

*********
ETF Battles is sponsored by:
Direxion Daily Leveraged & Inverse ETFs. If you’re ready for a bold trade, visit http://www.Direxion.com

*********
Get in touch with our judges:
ETF.com
https://www.ETF.com

ETF Portfolio Management
http://www.ETFpm.com

*********
–YOUR RESOURCES FROM RON–
Get help with your investing habits https://tinyurl.com/2xrpbzz8
Get help building your investment portfolio https://tinyurl.com/yrrx5ue2
Get feedback on your portfolio’s risk https://tinyurl.com/cz4ahj52
Check your investment performance https://tinyurl.com/cz4ahj52
60 Smart Ways to Retire Better https://60-smart-ways.etfguide.com/
Talk with Ron: https://tinyurl.com/dfhn863t

*********
–LISTEN TO ETF BATTLES–
1) Spotify

2) iTunes
https://podcasts.apple.com/us/podcast/etf-battles-podcast/id1557945852
3) Amazon Music
https://music.amazon.com/podcasts/2803a335-e5dc-497b-bcdf-c4528b24b777/ETF-Battles-Podcast
4) Google Podcasts
https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5idXp6c3Byb3V0LmNvbS8xNzI5OTU5LnJzcw==

#Genomics #ETF #Biotech

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Your Resources From ETFguide

Get Feedback on Your Portfolio's Risk

Check Your Investment Performance

Get Help With Your Investing Habits

60 Smart Ways to Retire Better